Ireland
--:--IST
Latest
Clinical Trials in Spain / NCT07569796
Recruiting Not applicable

Effectiveness of Stimulation on the Sciatic Nerve in ACLR

NCT07569796 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-12-01
Last updated
2026-05-06

Condition(s) studied

Anterior Cruciate Ligament Reconstruction Rehabilitation

Investigational drug(s) / intervention(s)

Experimental Group

Experimental Group: Percutaneous Electrical Nerve Stimulation on the Sciatic Nerve

Study summary

After randomization, the control group will receive conventional physiotherapy, including manual therapy and therapeutic exercise for ACL rehabilitation. The first experimental group will undergo percutaneous electrical nerve stimulation of the sciatic nerve, while the second experimental group will receive a placebo stimulation. Both interventions aim to improve isometric strength, muscle activation, joint range of motion, and thigh circumference, as well as reduce pain and intra-articular effusion. The procedure involves needle insertion into the sciatic nerve epineurium, placement of a surface electrode on the hamstrings, and connection to an electrostimulator.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * Use of the Semitendinous and Gracilis tendons for ACL Reconstruction * Joint Range of Motion greater than or equal to 90 * Primary ACL injury in the leg to be treated Exclusion Criteria: * Chronic or rheumatic joint disease * Central nervous system disorder * Heart disease (pacemaker) * Neoplasms * Epilepsy * Coagulopathies (use of anticoagulants) * History of spinal surgery or lumbar disease * History of neurological disorders * Prosthesis or osteosynthesis in the operated leg * Structural discrepancy in lower-limb length * Belonephobia (overwhelming fear of needles) * Neuropathic pain or bilateral symptoms * Use of analgesics * Quadriceps tendon graft harvest * Body mass index \<20 or \>30 kg/m² * Acute muscle injuries * Knee joint instability * Acute joint inflammation

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Clinica CEMTRO, Montecarmelo, Madrid Madrid Madrid Recruiting

More Universidad de Murcia trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07569796 on ClinicalTrials.gov ↗ ← All trials in Spain